ArticleFrontiers in pharmacology2025

Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a

Sebastian Majewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.